ATSN-201 Clinical Trials (2026): 1 Studies for X-linked Retinoschisis
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 ATSN-201 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including X-linked Retinoschisis) and 97 total planned enrollment. 1 Phase 3 ATSN-201 trial are listed. 1 ATSN-201 clinical trial is actively recruiting at 4 U.S. sites across 4 states. Most recent activity: NCT05878860 (Apr 2033).
Where to Participate: All ATSN-201 Trial Sites in the U.S. (4 sites across 4 states)
Every actively recruiting ATSN-201trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | Children's Hospital of Los Angeles | Los Angeles90027 | NCT05878860 | Map |
| FL | Bascom Palmer Eye Institute | Miami33136 | NCT05878860 | Map |
| OR | Oregon Health Sciences University | Portland97239 | NCT05878860 | Map |
| PA | Children's Hospital of Philadelphia | Philadelphia19104 | NCT05878860 | Map |
ATSN-201 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P3 | 1 | 1 |
Recruiting ATSN-201 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT05878860 | LIGHTHOUSEATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis | P3 | X-linked Retinoschisis | 97 | Aug 2023 |
ATSN-201 pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| LIGHTHOUSE | NCT05878860 | P3 | recruiting | X-linked Retinoschisis | 97 | — |
All ATSN-201 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT05878860 | LIGHTHOUSE | ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis | P3 | recruiting | 97 | Atsena Therapeutics Inc. | Aug 2023 |
ATSN-201 clinical trials: frequently asked questions
- How many ATSN-201 clinical trials are there?
- 1 ATSN-201 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are ATSN-201 clinical trials recruiting in 2026?
- Yes — 1 ATSN-201 trial is actively recruiting in 2026, with 4 U.S. sites across 4 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is ATSN-201 being studied for?
- ATSN-201 is being studied for X-linked Retinoschisis. The trials are grouped by indication on this page.
- What phase is ATSN-201 in?
- ATSN-201 clinical trials span 1 Phase 3. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors ATSN-201 clinical trials?
- The lead sponsor across the most ATSN-201 trials is Atsena Therapeutics Inc.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming ATSN-201as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: